These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 35704741)
1. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients. Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741 [TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027 [TBL] [Abstract][Full Text] [Related]
3. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance]. Karabıçak N; Alem N Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336 [TBL] [Abstract][Full Text] [Related]
4. Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011. Li F; Wu L; Cao B; Zhang Y; Li X; Liu Y BMC Infect Dis; 2013 Jul; 13():353. PubMed ID: 23899244 [TBL] [Abstract][Full Text] [Related]
5. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783 [TBL] [Abstract][Full Text] [Related]
7. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study. Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC; J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305 [TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia. Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913 [TBL] [Abstract][Full Text] [Related]
10. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp]. Ricciardi AM; Ricciardi R; Danzi M; Mungiguerra M; Pisano L; Marino A Infez Med; 2009 Mar; 17(1):24-7. PubMed ID: 19359821 [TBL] [Abstract][Full Text] [Related]
12. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study. Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R; J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Wang H; Xu YC; Hsueh PR Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452 [TBL] [Abstract][Full Text] [Related]
14. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
15. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran. Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study. Lei J; Xu J; Wang T J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China. Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354 [TBL] [Abstract][Full Text] [Related]
18. Wang B; He X; Lu F; Li Y; Wang Y; Zhang M; Huang Y; Xia J Front Public Health; 2021; 9():779590. PubMed ID: 34858938 [No Abstract] [Full Text] [Related]
19. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. Mokaddas EM; Al-Sweih NA; Khan ZU J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients. Mohammadi F; Charkhchian M; Mirzadeh M BMC Oral Health; 2023 May; 23(1):261. PubMed ID: 37143002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]